Australia’s pharmaceutical benefits scheme is not up for negotiation, says the federal government in the face of ramped-up US ...

The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

The deadline on US pharmaceutical tariffs has been dramatically brought forward, in the latest escalation of Donald Trump's ...